Biotech - Press Releases

Date	Title	Company
21-Nov-2023	Cherwell welcomes new recruits as pharma environmental monitoring needs grow	Cherwell
21-Nov-2023	UK Medical Devices Regulations: TÜV Rheinland is now a UK Approved Body according to UK MDR	TÜV Rheinland
21-Nov-2023	Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics	Myricx Bio
21-Nov-2023	Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM	Vironova BioAnalytics
21-Nov-2023	EDX MEDICAL & THERMO FISHER SCIENTIFIC TO COLLABORATE ON DEVELOPMENT OF INNOVATIVE CANCER TESTS FOR GLOBAL MARKETS	EDX Medical Group plc
21-Nov-2023	Biocomposites expands its product portfolio with the launch of SYNICEMTM spacers in the UK	Biocomposites
21-Nov-2023	Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes	ViCentra B.V.
21-Nov-2023	European Commission Approves pharmaand GmbH’s Rubraca® (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer	pharmaand GmbH
21-Nov-2023	Amerigo Scientific Introduces Hydrazide Gel Kit for High-Yield Protein Purification	Amerigo Scientific
21-Nov-2023	CD Formulation Offers a 10% Discount on All Products and Services as Thanksgiving Greetings for 2023	CD Formulation
21-Nov-2023	This Thanksgiving, Alfa Chemistry Extends Gratitude with Special Offers	Alfa Chemistry
20-Nov-2023	Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment	Landmark medicines
20-Nov-2023	“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential	Inizio
20-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
20-Nov-2023	bit.bio's new human iPSC-derived microglia, for reproducible, scalable, and faster neurodegenerative and neuroinflammation research and screening	bit.bio
20-Nov-2023	Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6	Omnix Medical
17-Nov-2023	Leading biotech company awarded prestigious Innovate UK grant to expand search for rare disease therapies	SynaptixBio
17-Nov-2023	BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma	BeiGene
17-Nov-2023	Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence	Versameb AG
17-Nov-2023	Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards	Amolyt Pharma